Print this page    •   Back to Web version of article

Say NO to Novartis!

March 19, 2012

Novartis, the Swiss-based pharmaceutical giant, continues its assault on India's generic pharmaceutical industry -- legally challenging India's patent law that allows the nation to supply nearly 80% of the developing world's access to high-quality, affordable, life-saving medications.

India's patent law effectively stops evergreening, a tactic used by pharmaceutical companies to make minor tweaks on medications to extend their stranglehold on a patent that is about to expire.

Should Novartis succeed on March 28th, a dangerous precedent will be set ...

With a chain-reaction of serious consequences.

The costs?

Crippling the generic pharmaceutical industry

Making essential medications even more cost-prohibitive

Cutting off the supply of medications used by NGO's worldwide

Millions of lives that are dependent on these drugs to fight diseases like HIV/AIDS.

Say NO to Novartis

Send the message to Novartis that no loss of human life can ever be tolerated for profits, by signing a petition here.

Learn more on how to Occupy Pharma by joining our working group.




This article was provided by HIV Prevention Justice Alliance. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/66322/say-no-to-novartis.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.